How Big of a Deal Is Axsome Therapeutics' New Depression Drug? Motley Fool
How Big of a Deal Is Axsome Therapeutics' New Depression Drug? Nasdaq
What We're Reading: More Teens Vape Marijuana; Improving Organ Donation; CVS vs the US Government AJMC.com Managed Markets Network
Starbucks Earnings: Mark Your Calendar Nasdaq
Aiming for zero suicides AAMC
Antidepressant use by children jumps more than 20% after a school shooting, data show The Washington Post
Where Will Sprint Be in 1 Year? Nasdaq
Stock Alert: Shares Of Model N Inc. (MODN) Hit All-Time High Nasdaq
Over Half of All American Shoppers Will Subscribe to Amazon Prime Next Year Nasdaq
Magic mushroom trial finds psilocybin compound safe for treatment of depression The Independent
